FDA Inspection
Haemonetics Manufacturing, Inc.Haemonetics Manufacturing, Inc. – FDA Inspection, May 15, 2018
Record Details
This FDA Inspection record concerns Haemonetics Manufacturing, Inc., with an inspection on May 15, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · b0681d81-1b33-4e30-8cb0-79a94c3fac2e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1053259
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.194(a)Complete test data included in records
- 21 CFR 211.68(b)Computer control of master formula records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Haemonetics Manufacturing, Inc.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| May 1, 2026 | Not classified | Los Angeles District Office | Blood and Blood Products |
| September 22, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 25, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 27, 2018 | Not classified | Los Angeles District Office | |
| August 19, 2014 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for Haemonetics Manufacturing, Inc.
- FDA Inspection 1314924 - 2026-05-01
- FDA Inspection 1219069 - 2023-09-22
- FDA Inspection 1109177 - 2019-09-25
- FDA Inspection 1128913 - 2018-09-27
- FDA Inspection 891996 - 2014-08-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.